Search results for "OXIDE"

showing 10 items of 6424 documents

Genotype-driven pharmacokinetic simulations of warfarin levels in Puerto Ricans.

2020

Abstract Objectives The inter-individual variability of warfarin dosing has been linked to genetic polymorphisms. This study was aimed at performing genotype-driven pharmacokinetic (PK) simulations to predict warfarin levels in Puerto Ricans. Methods Analysis of each individual dataset was performed by one-compartmental modeling using WinNonlin®v6.4. The k e of warfarin given a cytochrome P450 2C9 (CYP2C9) genotype ranged from 0.0189 to 0.0075 h−1. K a and V d parameters were taken from literature. Data from 128 subjects were divided into two groups (i.e., wild-types and carriers) and statistical analyses of PK parameters were performed by unpaired t-tests. Results In the carrier group (n=6…

medicine.medical_specialtyGenotypeCmax030204 cardiovascular system & hematology030226 pharmacology & pharmacyGastroenterologyArticle03 medical and health sciences0302 clinical medicinePharmacokineticsVitamin K Epoxide ReductasesInternal medicineGenotypemedicineHumansPharmacology (medical)DosingGeneral Pharmacology Toxicology and PharmaceuticsCYP2C9GenotypingCytochrome P-450 CYP2C9business.industryWarfarinArea under the curveFarmàcia InvestigacióAnticoagulantsHispanic or LatinoAryl Hydrocarbon HydroxylasesWarfarinbusinessmedicine.drugDrug metabolism and personalized therapy
researchProduct

Characterization of nitric oxide synthase isoforms expressed in different structures of the guinea pig cochlea.

1997

Nitric oxide synthase (NOS) activity and NADPH diaphorase staining has previously been reported in mammalian cochlea. Here we demonstrate immunoreactivity for neuronal-type NOS I and endothelial-type NOS III in the cochlea of the guinea pig. NOS I immunoreactivity was seen in inner and outer hair cells, and spiral ganglion cells. Staining for NOS I was also shown in basal and intermediate cells of the stria vascularis, spiral ligament cells, and the media of vessels near the modiolus. An antibody to NOS III stained primarily vascular endothelial cells. Some NOS III immunoreactivity was also detected in spiral ganglion cells. An antibody to the inducible-type NOS II did not stain any structu…

medicine.medical_specialtyGuinea PigsBiologyNitric oxidechemistry.chemical_compoundInternal medicineHair Cells Auditoryotorhinolaryngologic diseasesmedicineAnimalsEndotheliumMolecular BiologyCochleaSpiral ganglionGeneral NeuroscienceMicrocirculationNADPH DehydrogenaseMolecular biologyImmunohistochemistryCochleaNitric oxide synthaseIsoenzymesmedicine.anatomical_structureModiolus (cochlea)EndocrinologychemistryOrgan of CortiSpiral ligamentbiology.proteinsense organsNeurology (clinical)Hair cellNitric Oxide SynthaseSpiral GanglionDevelopmental BiologyBrain research
researchProduct

Increase by NO synthase inhibitors of acetylcholine release from guinea-pig myenteric plexus

1994

The effects of nitric oxide (NO) synthase inhibitors on the electrically evoked release of [3H]acetylcholine were studied in guinea-pig myenteric plexus preparations preincubated with [3H]choline. NG-monomethyl-L-arginine (EC50 5.3 mumol l-1) and NG-nitro-L-arginine (EC50 1.3 mumol l-1) concentration-dependently increased the evoked release of [3H]acetylcholine without affecting the basal outflow. The facilitatory effect of NG-mono-methyl-L-arginine was prevented by L-arginine but not by D-arginine. The results suggest that endogenous NO inhibits the depolarisation-evoked release of acetylcholine.

medicine.medical_specialtyGuinea PigsMyenteric PlexusArginineNitric OxideNitroarginineNitric oxideGuinea pigchemistry.chemical_compoundInternal medicinemedicineAnimalsCholineEvoked PotentialsMyenteric plexusPharmacologyomega-N-MethylargininebiologyMuscle SmoothGeneral MedicineAcetylcholineElectric StimulationNitric oxide synthaseEndocrinologychemistryEnzyme inhibitorbiology.proteinLiberationAmino Acid OxidoreductasesNitric Oxide SynthaseAcetylcholinemedicine.drugNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct

Ambient carbon monoxide and daily mortality:a global time-series study in 337 cities

2021

Background Epidemiological evidence on short-term association between ambient carbon monoxide (CO) and mortality is inconclusive and limited to single cities, regions, or countries. Generalisation of results from previous studies is hindered by potential publication bias and different modelling approaches. We therefore assessed the association between short-term exposure to ambient CO and daily mortality in a multicity, multicountry setting. Methods We collected daily data on air pollution, meteorology, and total mortality from 337 cities in 18 countries or regions, covering various periods from 1979 to 2016. All included cities had at least 2 years of both CO and mortality data. We estimat…

medicine.medical_specialtyHealth (social science)OzoneAir pollutionMedicine (miscellaneous)Time Series610 Medicine & health010501 environmental sciencesmedicine.disease_cause01 natural sciencesDaily mortalityArbetsmedicin och miljömedicin03 medical and health scienceschemistry.chemical_compound0302 clinical medicine360 Social problems & social servicesAir PollutionEnvironmental healthEpidemiologyRisk of mortalitymedicineHumansNitrogen dioxide030212 general & internal medicineCities610 Medicine & healthAir quality indexlcsh:Environmental sciences0105 earth and related environmental sciencesMCClcsh:GE1-350PollutantAir PollutantsCarbon MonoxideHealth PolicyPublic Health Environmental and Occupational HealthPublic Health Global Health Social Medicine and EpidemiologyOccupational Health and Environmental HealthParticulatesAmbient carbon monoxideFolkhälsovetenskap global hälsa socialmedicin och epidemiologicarbon monoxide mortalitychemistryCardiovascular DiseasesEnvironmental scienceDeterminantes da Saúde e da DoençaGenotoxicidade Ambiental360 Social problems & social services
researchProduct

Basal release of nitric oxide in the mesenteric artery in portal hypertension and cirrhosis: Role of dimethylarginine dimethylaminohydrolase

2013

Background and Aim Increased basal release of nitric oxide (NO) in the splanchnic circulation contributes to elevated plasma levels of NO observed in decompensated cirrhosis. We evaluated in rat mesenteric arteries whether the differences in basal release of NO, revealed by asymmetric dimethylarginine (ADMA)- and NG-nitro-L-arginine methyl ester (L-NAME)-induced contractions, were associated with changes in messenger RNA (mRNA) expression of endothelial NO synthase (eNOS) and dimethylarginine dimethylaminohydrolases (DDAHs). Methods Rat small mesenteric arteries from 14 Sham-control, from 14 with partial portal vein ligation (PPVL), and from 14 with bile duct excision (BDE)-induced cirrhosi…

medicine.medical_specialtyHepatologybiologybusiness.industryGastroenterologyVasodilationmedicine.diseasebiology.organism_classificationApaminNitric oxidechemistry.chemical_compoundEndocrinologymedicine.anatomical_structurechemistryEnosInternal medicinemedicinePortal hypertensionbusinessAsymmetric dimethylarginineMesenteric arteriesArteryJournal of Gastroenterology and Hepatology
researchProduct

Murine genetic deficiency of neuronal nitric oxide synthase (nNOS-/-) and interstitial cells of Cajal (W/Wv): Implications for achalasia?

2014

Background and aim Nitric oxide (NO) is an important inhibitory mediator of esophageal function, and its lack leads to typical features of achalasia. In contrast, the role of intramuscular interstitial cells of Cajal (ICC-IM) and vasoactive intestinal peptide (VIP) in lower esophageal sphincter (LES) function is still controversial. Therefore, we examined the function and morphology of the LES in vivo in NO-deficient (nNOS(-/-) ), ICC-IM-deficient (W/W(v) )-, and wild-type (WT) mice. Methods Esophageal manometry was performed with a micro-sized transducer catheter to quantify LES pressure, swallow evoked LES relaxation, and esophageal body motility. The LES morphology was examined by semiqu…

medicine.medical_specialtyHepatologybusiness.industryVasoactive intestinal peptideGastroenterologyMotilityAchalasiaInhibitory postsynaptic potentialmedicine.diseaseNitric oxideInterstitial cell of Cajalchemistry.chemical_compoundsymbols.namesakeEndocrinologychemistryIn vivoInternal medicineotorhinolaryngologic diseasesmedicinesymbolsbusinessNeuronal Nitric Oxide SynthaseJournal of Gastroenterology and Hepatology
researchProduct

Disposable chlorine dioxide wipes for high-level disinfection in the ENT department: A systematic review

2020

Abstract Background Nasopharyngoscope reprocessing methods should be effective, rapid and reproducible with moderate cost. Tristel Trio Wipes system (TTWS) is a manual reprocessing method based on chlorine dioxide that has lately emerged in ENT department. This review aims to collect evidence on this system. Methods The PubMed, Web of Science and Cochrane Library databases were searched for all the studies on TTWS or one of its components. Data were grouped according to the study type. Results Ten articles were included in the review. TTWS ensured high-level disinfection in laboratory and clinical setting. Although the limitations of the manual systems, TTWS proved to be faster than automat…

medicine.medical_specialtyHigh-level disinfection (HLD)NasopharyngoscopeWeb of scienceChlorine compoundHospital DepartmentsNasopharyngoscopesCochrane LibraryLaryngoscopesChlorine dioxideChlorine compounds; Chlorine dioxide; Decontamination; Disinfection; Endoscopes; High-level disinfection (HLD); Laryngoscopes; Nasopharyngoscopes; Otolaryngology; Reprocessing03 medical and health scienceschemistry.chemical_compoundOtolaryngology0302 clinical medicineLaryngoscopesEndoscopemedicine030223 otorhinolaryngologyDecontaminationEndoscopesChlorine dioxidebusiness.industryStudy TypeENT departmentOxidesmedicine.diseaseDisinfectionReprocessingNasopharyngoscopesOtorhinolaryngologyOtorhinolaryngologychemistry030220 oncology & carcinogenesisLaryngoscopeEquipment ContaminationMedical emergencybusinessChlorine Compounds
researchProduct

Vitrification of zona-free rabbit expanded or hatching blastocysts: a possible model for human blastocysts.

2003

BACKGROUND: The purpose of this study was to test the effectiveness of one two-step (A) and two one-step (B1 and B2) vitrification procedures on denuded expanded or hatching rabbit blastocysts held in standard sealed plastic straws as a possible model for human blastocysts. The effect of blastocyst size was also studied on the basis of three size categories (I: diameter <200 μm; II: diameter 200-299 μm; III: diameter ≥300 μm). METHODS: Rabbit expanded or hatching blastocysts were vitrified at day 4 or 5. Before vitrification, the zona pellucida was removed using acidic phosphate buffered saline. For the two-step procedure, prior to vitrification, blastocysts were pre-equilibrated in a solut…

medicine.medical_specialtyHot TemperatureZona freeBiologyAndrologychemistry.chemical_compoundEmbryonic and Fetal DevelopmentmedicineAnimalsHumansVitrificationBlastocystZona pellucidaZona PellucidaCryopreservationTissue SurvivalDimethyl sulfoxideHatchingRehabilitationHistological TechniquesObstetrics and GynecologyEmbryoSurgerymedicine.anatomical_structureBlastocystReproductive MedicinechemistryModels AnimalFemaleRabbitsEthylene glycolHuman reproduction (Oxford, England)
researchProduct

Treatment of pulmonary hypertension in patients undergoing cardiac surgery with cardiopulmonary bypass: a randomized, prospective, double-blind study

2006

Pulmonary hypertension can already be present in patients undergoing cardiac surgery or can be exacerbated by cardiopulmonary bypass. Postoperative treatment is still a challenge for physicians. The aim of this study was to evaluate the effects of inhaled prostacyclin (iPGI2) and nitric oxide (iNO) compared with those of intravenous vasodilators.This prospective, randomized, double-blind study included 58 patients affected by severe mitral valve stenosis and pulmonary hypertension with high pulmonary vascular resistance (250 dynes x s x cm(-5)) and a mean pulmonary artery pressure25 mmHg. All patients were monitored by central venous, radial arterial and Swan-Ganz catheters. Data were recor…

medicine.medical_specialtyHypertension PulmonaryHemodynamicsProstacyclinVasodilationNitric Oxidelaw.inventionDouble-Blind MethodRandomized controlled triallawInternal medicineAdministration InhalationCardiopulmonary bypassmedicineHumansMitral Valve StenosisProspective StudiesProspective cohort studyAntihypertensive AgentsAgedCardiopulmonary Bypassbusiness.industryfungiHemodynamicsfood and beveragesGeneral MedicineLength of StayMiddle Agedmedicine.diseaseEpoprostenolPulmonary hypertensionBronchodilator AgentsCardiac surgeryAnesthesiaCardiologyCardiology and Cardiovascular Medicinebusinessmedicine.drugJournal of Cardiovascular Medicine
researchProduct

Inhaled nitric oxide as a rescue therapy in a preterm neonate with severe pulmonary hypertension: a case report

2018

Abstract Background Inhaled nitric oxide (iNO) has been approved for the treatment of persistent pulmonary hypertension of the newborn (PPHN) in term and near-term newborns. Its role in the management of persistent pulmonary hypertension in preterm infants is not clear. Although guidelines do not exist, some studies have shown that iNO could be used as a rescue therapy in preterm neonate with severe pulmonary hypertension. Case presentation We describe the case of a preterm neonate, born at 30 + 1 weeks of gestation, with hypoxic respiratory failure not responding to maximal conventional therapy. On the third day of life echocardiography showed severe pulmonary hypertension with right to le…

medicine.medical_specialtyHypertension PulmonaryRight-to-left shuntDay of lifeCase ReportInfant Premature DiseasesNitric OxidePulmonary hypertensionNitric oxide03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRescue therapy030225 pediatricsInternal medicinemedicine.arteryAdministration InhalationHumansMedicine030212 general & internal medicinebusiness.industryPersistent pulmonary hypertensionPreterm neonatelcsh:RJ1-570Infant Newbornlcsh:PediatricsGeneral Medicinemedicine.diseasePulmonary hypertensionBronchodilator AgentschemistryRespiratory failureCardiologyGestationFemalebusinessInfant PrematureInhaled nitric oxideItalian Journal of Pediatrics
researchProduct